Improving access to healthcare is an important mission as a pharmaceutical company.
Unmet medical needs and access barriers to essential healthcare caused by social factors such as public health, education and income inequality are social issues related to health and medical care.
The Daiichi Sankyo Group is committed to access to healthcare across its entire value chain, focusing on three key areas: Research and Development, Availability, and Capacity Building.
Daiichi Sankyo Group Policy on Access to Healthcare
The Daiichi Sankyo Group works to address access to healthcare across its entire value chain, which spans everything from research and development to manufacturing, sales & marketing, and quality & safety management, and prioritizes the following three areas: Research and Development, Availability, and Capacity Building.
View More